Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pramlintide

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

AstraZeneca · Phase 2 · Completed · Enrollment 258

NCT00402077

ArmPopulationDoseWeeksEstimandWeight change
1Obesity or overweightn/rn/rn/rn/r
2Obesity or overweightn/rn/rn/rn/r
3Obesity or overweightn/rn/rn/rn/r
4Obesity or overweightn/rn/rn/rn/r